Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target

MLA

Carlos Guijarro, and Luis M. Ruilope. “Cholesterol Associated to Low Density Lipoproteins (LDL) and Vascular Risk Reduction. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): A New Therapeutic Target.” Medicina Clínica (English Edition), vol. 145, July 2015, pp. 67–69. EBSCOhost, https://doi.org/10.1016/j.medcle.2015.04.002.

APA

Carlos Guijarro, & Luis M. Ruilope. (2015). Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target. Medicina Clínica (English Edition), 145, 67–69. https://doi.org/10.1016/j.medcle.2015.04.002

Chicago

Carlos Guijarro, and Luis M. Ruilope. 2015. “Cholesterol Associated to Low Density Lipoproteins (LDL) and Vascular Risk Reduction. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): A New Therapeutic Target.” Medicina Clínica (English Edition) 145 (July): 67–69. doi:10.1016/j.medcle.2015.04.002.